Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ BioMed Valley Discoveries, Inc
BioMed Valley Discoveries, Inc
Industry · 10 registered clinical trials.
Status
Trial
Phase
Started
Terminated
Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Ma
Tumor, Solid, Gastrointestinal Cancer
Phase 2
2022-05-26
Terminated
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations
Advanced Solid Tumor, BRAF Gene Mutation, BRAF Gene Alteration
Phase 2
2021-01-07
Completed
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers
Healthy
Phase 1
2017-01-01
Completed
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic
Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase 1 / Phase 2
2014-11-01
Completed
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That
Solid Tumor Malignancies
Phase 1
2013-10-01
Terminated
[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection
Diabetic Foot Infection
Phase 2
2013-04-01
Completed
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advance
Advanced Solid Tumors
Phase 1 / Phase 2
2013-03-01
Terminated
[124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint
Prosthetic Joint Infections
Phase 2
2012-08-01
Terminated
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Sta
Solid Tumor Malignancies
Phase 1
2011-04-01
Completed
Biodistribution and Dosimetry Evaluation of [124I]FIAU
Prosthesis Related Infections
Phase 1
2010-12-01